NBSE(Delisted)
NeuBase Therapeutics·NASDAQ
--
--(--)
NBSE Filings
Filing Date
Form Description
Form Type
2025-01-13
Form 15-12G - Securities registration termination [Section 12(g)]
Key Events
2025-01-13 · Key Events
Form 15-12G - Securities registration termination [Section 12(g)]
2025-01-07
Form 8-K - Current report
Key Events
2025-01-07 · Key Events
Form 8-K - Current report
2024-07-03
Form EFFECT - Notice of Effectiveness
2024-07-03 ·
Form EFFECT - Notice of Effectiveness
2024-07-03
Form EFFECT - Notice of Effectiveness
2024-07-03 ·
Form EFFECT - Notice of Effectiveness
2024-06-27
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-06-27 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-06-27
Form 15-12G - Securities registration termination [Section 12(g)]
Key Events
2024-06-27 · Key Events
Form 15-12G - Securities registration termination [Section 12(g)]
2024-06-27
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-06-27 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-06-27
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-06-27 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-06-27
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-06-27 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-06-27
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Ownership
2024-06-27 · Ownership
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
